Results 41 to 50 of about 19,613 (216)

Overlapping Infection by Strongyloides spp. and Cytomegalovirus in the Immunocompromised Host: A Comprehensive Review of the Literature

open access: yesTropical Medicine and Infectious Disease, 2023
Strongyloides and cytomegalovirus co-infections are rarely reported, even though they are distinguished by high morbidity and mortality, especially in immunocompromised hosts.
Tommaso Lupia   +17 more
doaj   +1 more source

Strongyloides stercoralis in sputum [PDF]

open access: yesQJM, 2013
A 68-year-old man had the initial presentation of poor appetite, productive cough for 1 month and body weight loss for 10 kg in half a year. His medical history included bladder cancer and diabetes mellitus. Laboratory testing demonstrated a white blood count of 15 800 cells/μl with a neutrophil count of 11 060 (70%) cells/μl and eosinophil count of ...
C-U, Cheong, S-J, Gau, C-C, Lai
openaire   +2 more sources

Distribution and risk factors for Plasmodium and helminth co-infections: a cross-sectional survey among children in Bagamoyo district, coastal region of Tanzania [PDF]

open access: yes, 2015
Plasmodium and soil transmitted helminth infections (STH) are a major public health problem, particularly among children. There are conflicting findings on potential association between these two parasites.
Abdulla, S   +61 more
core   +1 more source

Síndrome de hiperinfección mortal por Strongyloides stercoralis en un paciente diabético y alcohólico de México [PDF]

open access: yes, 2020
Strongyloides stercoralis hyperinfection syndrome is a medical emergency that requires a high level of suspicion. Immunocompromised patients are at high risk of hyperinfection syndrome; however, malnutrition, alcoholism, and diabetes mellitus also need ...
Saldívar-Palacios, Roberto   +3 more
core   +1 more source

Th2/1 Hybrid Cells Occurring in Murine and Human Strongyloidiasis Share Effector Functions of Th1 Cells

open access: yesFrontiers in Cellular and Infection Microbiology, 2017
Infections by the soil-transmitted threadworm Strongyloides stercoralis affect 30–100 million people worldwide, predominantly in tropic and sub-tropic regions. Here we assessed the T helper cell phenotypes in threadworm-infected patients and experimental
Cristin N. Bock   +12 more
doaj   +1 more source

Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids

open access: yesEmerging Infectious Diseases, 2022
Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported ...
Jani M. Kim, Geetha Sivasubramanian
doaj   +1 more source

A Review on Strongyloidiasis in Pregnant Women

open access: yesResearch and Reports in Tropical Medicine, 2021
Philip Wikman-Jorgensen,1 Ana Requena-Méndez,2,3 Jara Llenas-García4,5 1Internal Medicine Department, Hospital Universitario San Juan de Alicante-FISABIO, San Juan de Alicante, Alicante, Spain; 2Barcelona Institute for Global Health (ISGlobal, Hospital ...
Wikman-Jorgensen P   +2 more
doaj  

Generating Transgenics and Knockouts in Strongyloides Species by Microinjection [PDF]

open access: yes, 2021
The genus Strongyloides consists of multiple species of skin-penetrating nematodes with different host ranges, including Strongyloides stercoralis and Strongyloides ratti. S.
Hallem, Elissa A.   +3 more
core   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement

open access: yesInternal Medicine Journal, EarlyView.
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy